Inhibition of degradation of extracellular matrix
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- AUSTRALIEN NAT UNIV
- Publication Date
- 2009-11-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] Cross references to related patent applications
[0002] This application claims priority based on Australian Provisional Patent Application No. 2006905854 filed on October 20, 2006, which is hereby incorporated by reference in its entirety. technical field
[0003] The present invention relates to the use of heparanase inhibitors in the treatment of disorders associated with degradation of the extracellular matrix, such as insulitis or autoimmune type 1 diabetes. In particular, the present invention relates to improvements in the efficacy of transplantation for the treatment of insulitis or type 1 diabetes. Background technique
[0004] Type 1 diabetes (T1D) is an autoimmune disease in which the insulin-producing beta cells of the pancreatic islets are destroyed. In humans, the disease has a dramatic impact on lifestyle, and imperfect control of hyperglycemia by exogenous insulin therapy inevitably leads to microvascular disease. This complication may eventually le...